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SNAKE VENOM: THE AM ZING POISON 
Prof. Tan Ngct I long 
Department of M lccular Medi me 
Faculty of Medicine, Uni rs ity f Malaya 
Kuala Lumpur, Malaysia 
Synopsis 
nakcbitc is a serious m idical problem in Malay ia. During th' p riod I 
1980, a many a 55000 ca cs or snakebites were admitted to the h pital · f 
Malaysia. In Malaysia there arc more than 0 different sp icics of cnorn u 
nakcs, belonging lo three families: the er la lids (pit ip ir), elapid: co ms and 
kraits) and the sea snake .. 
Dried snake venom contains mainly proteins (70-90%) and small amount· f 
metals, amino acids, peptides, nucle tides, arboh dratcs, lipids and biog .nic 
amines. The major to ins arc prot iins. In ·sti inti ns of th' bi ih nuistr nnd 
loxinology of snake venoms have I id to n b .u ir und irstnndin 1 of' th' 
path physiology of snake vcn 111 p i onings and impr crncnt in the trcntrn int 
of snakebites as well as the di covcry of no I th irnp iuti • n 1 .nrs and bi m 'di .nl 
loo ls. 
f auto-immune 
neuromuscular diseases such as Myasth inia gra is, and xin a ncurot xin f m 
Malayan krait, is a useful t I in the in cs rigs ti n f m I ult r b is f 









lltij SNAKE Vl!NOM: THE AMAZING POISON 
The crotalid venoms generally cause hemorrhages. For example, the victims of 
Malayan pit viper bite usually develop blood clotting defect due mainly to 
defibrination and thrombocytopenia. Defibrination is due to the action of the 
venom thrombin-like enzymes on the fibrinogen. The major thrombin-like 
enzyme, ancrod, has been used in anticoagulation therapy. Thrombocytopenia 
is presumably due to the combined actions of the platelet aggregation inducer, 
aggretin, and the anti-platelet L-amino acid oxidases and phospholipases A. 
Aggretin, a non-enzymatic protein, is an endothelial integrin a2p1 agonist which 
also induces angiogenesis. Other venom constituents of the Malayan pit viper 
that also contribute to the hemorrhagic actions of the venom include 
hemorrhagins and platelet aggregation inhibitors. The major hemorrhagin is 
rhodostoxin, a metalloproteinase which presumably degrades capillary basement 
membrane. Two platelet aggregation inhibitors, rhodostornin and rhodocetin, 
have been isolated from the venom. Rhodostomin is an ROG-containing 
polypeptide that blocks the binding offtbrinogen to the integrin a11bp3 of platelet 
whereas Rhodocetin acts as a2p1 integrin inhibiting disintegrin and may be a 
valuable tool to manipulate other a2p1 intcgrin mediated functions. 
Venomous snakes of Malaysia 
Snakebite is a serious medical problem in Malaysia. During the period 1958 to 
1980, as many as 55000 cases of snakebites were admitted to the hospitals of 
Malaysia (Lim and Ibrahim, 1970; Lim, 1982). While the mortality rate is only 
0.3 per 100000 population, snake venom poisoning can cause prolonged 
morbidity or even crippling deformity. 
Jn Malaysia there are at least 18 different species of venomous front fanged 
land snakes, and more than 22 different species of venomous sea nakes 
(Tweedie, 1983). These venomous snakes belong to the crotalid (pit viper) family 
(the genus Calloselasma and Trimeresurust, elapid family (the genus Naja, 
Bungarus and Ophiophagus) and sea snake family (the subfamilies Laticaudina ', 
Hydrophiini and Ephalophiiniy. Only a few of the Malaysian venomous snakes 
can be regarded as of medical importance, and these include the pit vipers 









(shore pit viper), Trimer stints 11 agleri ( aglcr ' pit iper) Trimere uru 
sumatranus ( urnatran pit vip r), the elapid aja naja sputatrix (Malayan 
cobra), Naja naja kaoutliia (M no llatc cobra), Ophiophagus Ha1111a!t (king 
cobra), Bungarus .andidns (Malayan krait) Bungarus fa ciatus (band d krait) 
and the sea snake Enhy drina s histosa (b aked ea nake). 
Table 1 summarizes the r port' on snakebites fr m monthly tausn f 2 
hospitals throughout Malaysia during the si -ycars p cri d 19 -1971 ( O\ ai et 
al, 1972). 
Table I: nakcbitcs in West Malaysia (1965-1971) 







I 4 o 
Malayan pit viper ( alloselastna r!todosto111u) 
ca snake 
Asian common .obrn (Naja IU(/u) 
Asian lunce-hcudcd viper (Tri111ff<'s111·11.1·) 




Composition of snake venom 
Dried snake venom contains mainly pr in (7 - 0% and small am nnus r 
metals, amino acids, p pt ides, nu 1 'oticks, arb h dratcs, lipids and biog, zni 
amines. The protein component includ b th cnz me and no11-1.~117 mati 
proteins. 
Ven ms of many clapid snak s cobra, krait and en . nak . ) pr du " fla id 









.. ,, SNAKE VENOM: THE AMAZING POISON 
polypeptide neurotoxins and certain phospholipases A. Elapid venoms also 
contain various pharmacologically active basic polypeptides. Jn cobra, the major 
basic polypeptides are polypeptide cardiotoxins. 
The major toxic principles in pit viper venoms are thrornbin-like enzymes, 
hemorrhagic proteases, platelet-aggregation inducers and inhibitors, as well as 
other enzymes that interfere with the blood coagulation pathway. 
Snake venoms consist of many other enzymes, including protease, L-amino 
acid oxidase, hyaluronidase, phosphodiesterase, alkaline phosphatase and 5- 
nucleotidase. Most of these enzymes play a role in the digestion of the prey but 
some also exhibit toxic properties. 
Elapid Venom Poisoning 
Elapid venoms (cobra, kraits and sea snakes) generally exhibit neurotoxicity 
and cardiotoxicity (Lee, 1972; Reid, 1964). The earliest symptom of systemic 
elapid poisoning is a feeling of drowsiness intoxication, difficulty in opening 
the eyes (bilateral ptosis). In severe poisoning, respiratory failure sets in rapidly. 
In cobra, these neurotoxic symptoms are cau ed by the polypeptide neurotoxins. 
These are postsynaptic neurotoxins, generally basic polypeptides containing 
60-70 amino acid residues with an intravenous LD50 (median lethal dose) of 
approximately 0.1 µg/g in mouse. Postsynaptic neurotoxins isolated from cobra, 
krait and sea snake venoms are very similar in their amino acid sequence. 
Toxinology of the Malayan cobra venom 
In Malayan cobra (Naja naja sputatrix) venom, postsynaptic neurotoxins account 
for approximately 5% of the venom dry weight. Two major ncurotoxins, with 
62 and 63 amino acid residues respectively, have been purified (Tan, 1983). 
The amino acid sequences of the two toxins have been elucidated ( hung 1 al, 














The ncuroioxin zones have also been clon d and pressed fifiyan t al, I 9 ) 
obra venom cardioto ricity i cau ed by polypeptide cardiot in that impair 
the tructure and function ofvariou cell , contributing to mu cle para! i and 
leading to circulatory failure and systolic arr' ·t ( c ', 1972). P 1 peptid 
cardiotoxins account for 60% or th' Malayan cobra en 111 b \ eight. Three 
polypc] tide cardioto .ins, sputa-cardioio in A, 8 and ha e b • in i · lated from 
the venom (Tan I 982a). hey arc basic polypcptid 'S with 
residue with intra cnous LI \o's f 1.0-1. I µ i/ 1 mouse. 
Jcyascclan '/o/(19 8)r'portedthc ·DN/\cloniniofth• urdiot tins and the 
deduced amino a rid sequences or the .nrdioto tins. Th· s • [u in • 'S urc 
homologous to other c bra cnom cardioto: ins. 
Malayan obra venom contains sub tantial quantit of'ph sph lipns 'S , ' hi h 
account for 15% or the venom dry w ·i iht. hrcc l nhul I hos] h lli1 ns .s 
sputatri PLA-1, sputatri · PLA-2 and sputatrix P 
I 982b; Tan and Arunmozhiurnsi. 198 ). h three '117 m 'S hn • intrnv ·n us 
LD50's of between 0.28-0.86 µg/g m u . putatri r P 
10% of the venom protein. It xhibit ' 
contracturc or muscle in a chick bi cnt r 
and Tan, 1988). putatri P A-2 and PL - 













,,,, SNAKE VENOM: THE AMAZING POISON 
Jeyaseelan et al (2000) reported the cloning of the phospholipase A genes from 
Malayan cobra venom. Comparison of the deduced amino acid sequences shows 
that the signal peptide sequences are conserved, and the three PLA's are highly 
homologous with slight variations only. 
Malayan cobra venom also causes extensive local necrosis. Our investigations 
indicated that the local necrosis is presumably caused by the synergistic action 
of cardiotoxin and phospholipase A (Tan and Arunmozhiarasi, 1990) 
Sea snake venom poisoning and the biochemistry of sea snake 
venom 
The commonest species of sea snake is the Enhydrina schistosa (beaked ea 
snake). In rat, its venom is neurotoxic acting mainly at the neuromuscular 
junction. Jn human, however, the venom is primarily rnyotoxic (Reid, 1979). 
The myonecrosis causes generalized muscle movement pains and myoglobinuria. 
Postsynaptic neurotoxins account for 70% of the venom dry weight.. The two 
major neurotoxins arc polypeptides with 60 amino acid residues and the amino 
acid sequences arc homologous to the cobra ncurotoxins. The venom contains 
more than 9 phospholipases A . .Thc major basic phospholipasc A which accounts 
for 7% of the venom dry weight has been isolated and demonstrate to exhibit 
strong myotoxic activity. Its sequence is similar to the PLA from other venom 
sources. Two acidic phospholipasess A have also been isolated (Tan, I 982c) 
and they are able to depress muscle excitability due to direct stimulation as well 
as the response of muscle to nerve stimulation. 
Venoms of King cobra and Malaysian kraits 
King cobra is one of the world's most dangerous snakes. The snake, however, is 
generally notaggressive and king cobra bite in man appears to be infrequent. 
King cobra venom has a much greater enzyme content than other cobra venoms 
The major lethal toxins are also polypeptide neurotoxins, and the main systemic 








SNAKE VENOM: THE AMAZING POISON ••• 
major hemorrhagin, the L-amino a id xida c and t\ o a idic pho pholipa e 
have been isolated (Tan and aifuddin, 19 9a,b, 1990) 
There arc three species of krait in Malay ia: Bungarus fa ciatu (banded krait) 
Bungarus andidus (Malayan krait) and 81111 arusflav icep (R d-h aded krait). 
The t.oxinology of the banded krait ha been in e tigated (Lu and , 19 I . 
We have isolat id two highly lethal phosph lipa ' A fr rn th Mala an krait 
(Tan >f al, 1989). it tic is kncx nab ut the to tin I gy of the R d-h ad d krait. 
Elapid toxins as biomedical tools 
Know led re about snake v ·110111 to ins may lead t unpro cm int of trcaun .nt 
of snake venom poisoning and development f cffccti c anti morn '. Be .idc s, 
the toxin arc al o valuable molecular probes and I hurma · 
wcll as providing lead compounds for the d 'sign of' .lini .all 
For example, postsynuptic ncuroio ins from obru and kruit cnoms pln an 
important role in th' und .rstnndin ! of th' pnthu •'II 'Sis f' uutc -inununc 
neuromuscular discus s such as Myasth 'ni<1 1r:1 is. nnd xin, :1 n iur itoxin 
isolated from Malayan krait, is a useful tool in th' in csti lat ion ifthe m I' .ulur 
basis of Alzheimer's disease. It is al. o a mus 'I· r .lnxant. bra .nrdi >t .ius, 
on the other hand, an act as inhibitors of' on iulntion and pint 'I 't n~ ire • uiou 1 
and a re carch tool in neurobiology b 
Pit Vipers in Malaysia 
Pit viper bites usually re. ult in S\I cllinu and . m 'tim \ lo "11 11 "1' sis. 'h' 
principal charactcristi ofsyst 'mi pit ip r p i:onin 1 in 
bleeding, characterized by lctibrinati n and thromb 
Warrell, 1986). 
he Malayan pit ipcr al/oselasma rhodo. tomn) pr~vi u. I kn ' n as 
sn k 'bit' in P~nin. ular 
i r di turb d. nunat I 
Agkistrodo11 rhodostrm1a, is lhc ·ommon 'St 









,,., SNAKE VENOM: THE AMAZING POISON 
only 10% of those bitten developed severe poisoning and death rate is less than 
2%. 
Clinical effects of Malayan pit viper Venom 
The intravenous LD50 for Malayan pit viper venom is 6. l µg/g mouse, which is 
considerably less lethal than cobra venom. This partially explains the low 
mortality rate of Malayan pit viper bites. 
Local swelling begins minutes after the bite and may continue to increase from 
24 to 72 hours. The swelling, which is due to the extravasations of plasma and 
red blood cells into tissue, results in discoloration. If large amount of venom 
has been injected, blisters may form around the bite followed by superficial 
necrosis. 
Systemic poisoning is characterized by systemic bleeding, which may be slight 
with only a prolonged clotting time or when severe, present as hemorrhagic 
syndrome with or without shock ( han 1979). The earliest manifestation of 
severe systemic poisoning is hcmoptysis. Other signs that followed arc continued 
oozing of blood from the wound site, gum bleeding, tooth sockets or ulcers, 
discoid hemorrhage. ·In severe systemic poisoning, the blood may remain 
incoagulablc for prolonged period. Reid t al. ( 1963) reported that the systemic 
bleeding is characterized by dcfibrination and thrombocytopenia. The major 
toxins of the Malayan pit viper venoms include thrombin-likc enzymes, 
hemorrhagins, platelet aggregation inducer, platelet aggregation inhibitors, L- 
amino acid oxidascs and phospholipases A (Tan and Ponnudurai, 1996). 
(i) Thrombin-like enzymes 
The venom contains several thrombin-likc enzymes. The major form, ancrod, 
accounts for approximately 7.5% of the venom dry weight (Esnouf'and Tunnah, 
1967). The enzyme coagulates fibrinogen solution by catalyzing the release of 
fibrinopeptide A, AP and A Y. Clots that formed with ancrod arc not cross-linked 
and are susceptible to rapid lysis by plasmin. When injected into human/animals, 
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virtually simultaneously dispo doff. Thus, although ancrod i a 'coagulant i11 
vitro, the in vivo effect i non- lotting bl d becau e of the very low fibrinogen 
level. The amino acid cqucncc ( u et al., 199 ) exhibit a high degr f 
sequence similarity to those or mammalian crinc protcina c a well a r ptilian 
fibrinogcnascs. 
The use of'ancrod in anti .oagulation therapy has b enc. arnin din many clinical 
trials. Ancrod provides optimal therapy f r patients ·u peered f ha ing heparin 
a sociatcd thrornbocytopcnia and thrombosis (HATT). D iplcti n f Iibrinog n 
with ancrod result in anticoagulation c mparablc to therapy' ith h parin within 
12 hours ( olc •t al., 1990). Ancrod ha also b icn u eel in th· trcatrn nt of 
acute ischaemic stroke ( hcrman et al., 2000) 
(ii) llcmorrhagins 
nakc venom hcmorrhagins arc generally 111 'tall pr t iinascs that pr abl a t 
by destruction or the colln •CnOUS bascm •nt 111 .mbranc and oth ir .onnc nivc 
tissue co Ila tens with ionscqu int w iak min 1 of th' bk od ·ss ·I wnll uusin 1 
hemorrhagic effect. 
The major Malayan pit viper cnorn h cmorrha >in, t .nnc I rh d st xin, hn · be •11 
isolated and its amino acid scqu incc is hornolo ious tc oth r ·110111 h 111 )1 rhu iins 
( hung ct al., 1996). It is a zinc-meta II pr t inas ·" ith _Q amino a .id rcsidu 'S 





Rhodostoxin is a potent hcrnorrha zin ' ith mom 
hcrnorrhagins but was not lethal to mi .c at a cl s i .. , indi atinu that 
it is not a major lethal factor or the morn ·1: th· D,0(i.1~) f nil an pit viper 
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Glycobiology of rhodostoxin 
Rhodostoxin is glycosylated with two N-linked glycopeptides attached to 
residues 91 and 181 (Chung et al., 1996). The glycan chain is a complex type of 
carbohydrate structure with novel 2,3-linked sialic acid and Gal~(J,3)GlcNAc 
linkages: 
NeuAca2-3Gal~l-3G lcNAc~l-2Manal '\. Fucal -, 
6 6 
Man~ 1-4G I cNAc~ 1-4G I cNAc- 
3 
NeuAca2-3Gal ~l-3G lcNAc~ l-2Mana I / 
Deglycosylation ofrhodostoxin results in an apparent increase in the stability 
of the hemorrhagin as well as an increased specificity (Tan et al., 1997). It 
appears that the glycol moieties ofrhodostoxin may play a role in the interaction 
between rhodostoxin and the relevant substrate in the membrane. 
Rhodostoxin is also known as kistomin. Jt inhibited angiogenesis in a doe- 
dependent manner and induced a1 optosis of human endothelial cell by 
degrading extracellular matrix. (Hsu and Huang, 2004). It may provide a potential 
strategy in exploring the apoptosis induction of endothelial cells and t:hc drug 
development in angiogenesis therapy. 
(iii) Platelet aggregation inducer 
Platelet aggregation occurs during vascular injury, and coverage of the expo cd 
subendothelium by platelets depends on the recognition of adhesive proteins 
(fibrinogen, collagen, vWF etc) by specific platelet membrane glycoprotein , 
many of which are integrins. Among them, a.2~1(GP1a/lla) and a.11b~J (GPllb/ 
Illa) are known to play important roles in mediating adhesion and aggregation 
of platelets. Snake venom platelet aggregation inducers are known to internet 
with the integrins. 
Malayan pit viper venom exhibits strong platelet aggregation inducing activity 
which contributes to the thromocytopenia in the victim. Huang ,, al. ( 19 5) 
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the venom. It is a heter dimeri prot in (-9 kDa) and is devoid of enzymatic 
activity. It ha been sugge ted that aggretin i an endothelial integrin a2~1 agoni t 
( hung et al., 200 I). tudy on the intera tion of platelet aggregation inducer 
and collagen would in rca c our knov I dgc of plat let-collagen interacti n at 
the molecular level and may pro id a new a cnu f r developing inhibitor to 
prevent detrimental effects of collagen. 
(iv) Platelet aggregation inhibitors 
Many crotalid snake venom contain polypeptide plat let aggregati n inhibit r 
known as disintcgrins. cncrally, the polypeptid di int grin contain rg- I - 
A p (RGD) tripeptide sequenc near its carb ·yl terminus, he tripeptidc R 
plays an essential r le in mediating the bind in 1 of a11h~,. 
Teng and Huan • ( 1991) reported the isolnti n of'u disintc zrin fr in ala an 1 it 
viper venom. Termed rh dost min, it is a i8 amino a id residu • p I p iptidc 
and inhibits platelet a )gr' rat ion by blo ikinu the bind in, r fibrin l '11 t th' 
integrin 0.1111~, of plate! ct. The a min a ·id s .qucnc · cl xluc id from th' ·D 
sequence (Au et ttl., 19c I) incli nt 'S thnt th' 18-nmin< u rid sc ~11 .nce r 
rhodo tom in is located at the carbo yl terminus of th i pr .curs r prot iin, whi .h 
al o conta in, the sequence of rhod 'toxin, th maj r h '111 rrhn iin. It up] .nrs 
that rhodostomin and rh do. to in share n ' mmon 1c11 • s iqu in cc, su r 1 istin 
that these proteins may be synergistic in fun ti n. Prcsumnbl , th· 
metal I protease de rradcs capj llar ba: m nt m .mbranc an I th' s lubl • 
rhodostomin then binds t platelet int )rin , inhibit in' pint 'I 't a• •r ·gnti n 
resulting in hem rrhage . 
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Wang et al ( 1999) reported the isolation of a different, RGD-independent platelet 
aggregation inhibitor from Malayan pit viper venom. Termed rhodocetin, it is a 
CLP (C-type lectin-Iike protein) that blocks a2p1 integrin and is responsible for 
hampering collagen-induced, a2p1 integrin-mediated platelet activation, leading 
to hemorrhages and bleeding disorders of the snakebite victims. Because of its 
high affinity to a2p1 integrin, rhodocetin may be a useful agent to study and 
influence a2P1 integrin-triggered cell function, like cell adhesion, cell migration 
or secretion of matrix metalloproteases. Thus, rhodocetin may help not only in 
treating thrombosis but also in treatments aimed to prevent tumor invasion and 
metastasis. 
(v) L-Amino acid oxidases 
L-Amino acid oxidase (LAAO) is a flavoprotein which catalyses the 
transformation of L-amino acids to the corresponding e-keto acids, with the 
concomitant release of hydrogen peroxide and ammonia. It is found in the 
venoms of most venomous snakes and contributes to the yellowish colour of 
the dry venom powder. LAAO is a major constituent of the Malayan pit viper 
venom, constituting 30% of the venom dried weight. The enzyme is an acidic 
glycoprotein with a molecular weight of I 32000 (Ponnudurai et al., 1994). The 
cDNA-deduced amino acid .scqucncc of the enzyme shows 83% identity to 
LAAOs from Eastern and Western diamondback rattlesnake (Machcroux et al., 
2001). 
LAAO is thought to contribute to the venom's toxicity, possibly through 
generation of hydrogen perox Ide formed as a result of the reaction it catalyzes. 
The hydrogen peroxide generate may cause impairment of platelet aggregation. 
The enzyme was not lethal but exhibited strong edema-inducing activity in rat. 
(vi) Phospholipase A2 enzymes 
Preliminary studies indicated the presence of four acidic phospholipasc A2 










of three acidic PLA2 and one ba i P _-h mo! g from the enom om of 
these phospholipa cs A e hibit anti-plat 'let acti it . 
(vii) Other venom constituents 
The venom contains at least four di fTcr nt ba ic pr tea e ' ith mol cular v eight 
of approximately 25000, all or, hich exhibit m dcratc edema inducing a ti it 
It also contains more than nine din! rent forms of arginine c t r hydr lase , (i c 
or which exhibit thrombin-like enzyme acti ity. Two min r ~ rrns or ar iin inc 
ester hydro lase also e hi bit arginine arnida activity (Tan, I 1 ). 
The venom als contains autopharmac logical fa nor that ma cause I cal 
swelling. The fa tors may release bradykinin which ' cntuall can lend to sho k. 
Like all other snake venoms, Mulayan pit ipcr cnom .on tu ins h uluroniduscs 
which arc hydrolyiic .nzyrn ·s that run nion as "spreading fo ·tt r ' of th · 
Malayan pit viper venom contain · high I' 'I or '<nu ·I· tidus · aciti it but 
moderate lo low I iv .ls of phosphodi 'st .rusc and alkaline phosph n1t no .st .rusc 
activities. Little is known about th' ioxi .olo ii .ul prop .rti s r th 'S' cnz m 'S. 
Antivcnorn therapy of make Venom Poisoning 
Anti venom therapy is the only pc iif treatment f snake en m I is niu • 
that is of'provcn valuc.Huscd corr ti ,it nu re .rsc most s stcmic p isouinu 
even when given hour and day after the bite, in th· 'as' f I it ip ir bit is. 
Antivcnom, however, i generally in cff ti 'in pr' cntiuu r lcsscninc I) .al 
nccr tic effects or snake cnorn p isonin '· 
The spcci lie, mono ul int uni i cnorns ar' m r' •l'f"ti\ anti I t' in snal-. •bit'. 
At present, howe er, only a few mon 'P ifi ani en m ar' availall • r r 
snakebites in Malaysia, and the·' in ·lud anti- 1lnl an pit ir •r, anti- bra. 
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Trimeresurus Antivenom (National Institute of Prventive Medicine, ROC) is 
effective against most Malaysian Trimeresurus venoms, and the Polyvalcnt 
Elapid Antivenom produced by the same institute is effective against Malaysian 
cobras and kraits (Tan, 1998). 
Application of Enzyme-linked Immunosorbent Assay (ELSA) 
in the diagnosis of the biting species 
The identification of the biting species is important so that the victim can be 
given the right type ofmonospecific antivenom. Diagnosis of the biting species 
can be ascertained by identification of the snake if the patient brings the snake 
to the hospital. In the absence of the snake, diagnosis can be made by clinical 
observations. Accurate diagnosis of the biting species, however, can be made 
by ELISA method. 
Double sandwich ELISA has been developed for the diagno is of bite cau cd 
by most Malaysian poisonous snakes (Tan et al., 1992). The LISA method is 
very specific and the venom concentration can be readily quantitated. 
Application of ELISA in snake venom research 
Information on serum kinetics of envenoming is important in the development 
of a personalized modality of treatment of snakebite, where the amount and 
frequency of anti venom administration is to be based on the amount or venom 
injected, and the kinetics of venom distribution in the body. For example, in 
experimental king cobra venom cnvcnornation, it was found that the level of 
the major lethal neurotoxin reached peak level 72 hours after the bite (Tan et al, 
1994). 
Prphylactic action of Mucuna pruriens against snakebite 
Seed of the Nigerian traditional medicinal plant Mucuna pruriens exhibits 
prophylactic action against snakebite in Nigeria, and it has also been used locally 
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prophylactic action of the e d is du t it ability t elicit antibodie that 
neutralize certain toxic ornpon nt f igcrian nake venom , including 
phospholipasc A. 
The irnmuorcactivity of mouse anti-Mucuna prurien extract (MP ) IgG again t 
the medically important Malaysian snake enoms wa e arnin du ing We t m 
blot analysi . Anti-MP lg react d again t me protein from n m of 
King cobra, Malnyun cobra, Malayan krait and Mala an pit ip r, but n t that 
of shore pit viper. 
The reactive protein in most of the cnorn appeared to b ph ph lipa es , 
indicating that MPE seed e tract shared common 'pit pe \ ith man nak 
venom phospholipasc A. I low· er, sc ·ral high mol · .ular \ ·i ht pr t ins in 
Malayan pit viper venom were also rcacti c. The prclimina tud suu • • ·t d 
that Mu ·1111a pruri '11s may als offer prophyla ti pr t 'Ct ion a rn inst 
snake vcn mp isoninc Marinello 1/ ol., _Q() . 
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